INDUSTRY NOTES A biotech startup will team up with Merck to educate physicians about HIV drug-resistance testing. ViroLogic Inc. and Merck & Co. Inc. will jointly develop and execute educational programs on the utility of HIV drug-resistance testing for physicians across the nation. ViroLogic is a South San Francisco, Calif.-based biotechnology company specializing in developing treatments for serious viral, immunologic, and oncologic diseases.
Register to view the full article
Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.
0 comments
Hide comments
